Last updated: March 6, 2025
Sponsor: Kessler Foundation
Overall Status: Active - Recruiting
Phase
N/A
Condition
Autism
Autism Spectrum Disorder (Asd)
Treatment
KF-STRIDE® Into Work!
Clinical Study ID
NCT06255925
E-1199-22
Ages 14-26 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Lives in the United States of America
Between the ages of 14-26
Speaks English well and at a 4th grade reading level
Exclusion
Exclusion Criteria:
Had a stroke, Traumatic Brain Injury, or neurological injury or disease in thepast(like brain tumor or epilepsy)
Has a history of significant psychiatric illness(like schizophrenia or psychosis)
Has uncontrolled seizures or other unstable medical complications
Study Design
Total Participants: 30
Treatment Group(s): 1
Primary Treatment: KF-STRIDE® Into Work!
Phase:
Study Start date:
January 01, 2023
Estimated Completion Date:
June 30, 2026
Study Description
Connect with a study center
Kessler Foundation
East Hanover, New Jersey 07936
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.